CD163 and breast cancer: These in vitro studies were further substantiated in primary murine mammary tumor tissue, through the co-staining of F4/80 with the iron transporter, Fpn1, the expression of the M2 marker CD163, and the loss of intracellular iron stores within TAMs as identified by Perl’s Prussian Blue staining.